Skip to main content
. 2019 Dec 2;19:206. doi: 10.1186/s12876-019-1124-8

Table 5.

Bleeding after colonic endoscopic mucosal resection in the management of continuous use of warfarin and one-day skip of DOAC

Bleeding HBTa
(n = 14)
Continuous use of warfarin (n = 10) One-day skip of DOAC (n = 27) Control
(n = 643)
n 3 1 4 20
Per-patient, % 21.4* 10.0 14.8* 3.1
Per polyp, % 9.7* 6.3 6.5* 1.5
Odds 4.94 3.29 4.94 1
(95%CI) (1.04–23.5) (0.40–27.2) (1.57–15.5)
p 0.045 0.27 0.0062

aHBTheparin bridging therapy, * v. s. Control, p < 0.05